Target Name: ODF3
NCBI ID: G113746
Review Report on ODF3 Target / Biomarker Content of Review Report on ODF3 Target / Biomarker
ODF3
Other Name(s): Outer dense fiber of sperm tails protein 3 | CT135 | Transcript induced in spermiogenesis protein 50 | sperm tail protein SHIPPO1 | Sperm tail protein SHIPPO 1 | SHIPPO1 | TISP50 | hSHIPPO | outer dense fiber of sperm tails 3 | Outer dense fiber of sperm tails 3, transcript variant 1 | Sperm tail protein SHIPPO1 | ODF3 variant 1 | Cancer/testis antigen 135 | transcript induced in spermiogenesis protein 50 | Outer dense fiber protein 3 | cancer/testis antigen 135 | ODF3A_HUMAN | Outer dense fiber protein 3 (isoform 1)

ODF3: A Potential Drug Target and Biomarker for Sperm Tails Protein 3

Sperm tails, also known as tail sperm, are a type of sperm that are produced in the testicles and play a crucial role in fertilization. They are composed of a protein called ODF3, which is also known as Outer dense fiber of sperm tails protein 3. ODF3 has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In this article, we will discuss ODF3 as a drug target and biomarker, its potential applications, and the research being conducted to investigate its effects.

Potential Drug Target

ODF3 is a key protein that is expressed in the sperm tail and is involved in the formation and maintenance of the tail structure. Its function is essential for the survival of sperm, and it has been shown to play a role in various biological processes, including fertilization, DNA replication, and cell signaling.

Recent studies have identified ODF3 as a potential drug target for various diseases. For example, ODF3 has been shown to be involved in the development and progression of cancer, including testicular cancer. In addition, ODF3 has also been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Biomarker

ODF3 can also be used as a biomarker for certain diseases. For example, ODF3 has been shown to be expressed in the brains of individuals with Alzheimer's disease, and its levels have been linked to the severity of the disease. In addition, ODF3 has also been shown to be involved in the development of certain autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis.

Research

ODF3 is a widely studied protein, and there is a growing body of research being conducted to investigate its functions and potential applications. Many studies have focused on the role of ODF3 in various biological processes, including fertilization, DNA replication, and cell signaling.

In addition, researchers have also been investigate ODF3 as a potential drug target and biomarker for various diseases. For example, studies have shown that ODF3 can be targeted with small molecules and antibodies to inhibit its function in the development of cancer and neurodegenerative diseases.

Conclusion

In conclusion, ODF3 is a protein that has been identified as a potential drug target and biomarker for various diseases. Its functions and potential applications continue to be investigated, and there is a growing body of research being conducted to understand its role in the development and progression of various diseases. Further studies are needed to determine the exact role of ODF3 in these diseases and to develop effective treatments.

Protein Name: Outer Dense Fiber Of Sperm Tails 3

Functions: Outer dense fibers are filamentous structures located on the outside of the axoneme in the midpiece and principal piece of the mammalian sperm tail. May help to maintain the passive elastic structures and elastic recoil of the sperm tail

The "ODF3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ODF3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ODF3B | ODF3L1 | ODF3L2 | ODF4 | ODR4 | OFCC1 | OFD1 | OGA | OGDH | OGDHL | OGFOD1 | OGFOD2 | OGFOD3 | OGFR | OGFR-AS1 | OGFRL1 | OGFRP1 | OGG1 | OGN | OGT | OIP5 | OIP5-AS1 | OIT3 | OLA1 | OLA1P1 | OLAH | OLFM1 | OLFM2 | OLFM3 | OLFM4 | OLFML1 | OLFML2A | OLFML2B | OLFML3 | OLIG1 | OLIG2 | OLIG3 | Oligosaccharyltransferase complex | OLMALINC | OLR1 | OMA1 | OMD | OMG | OMP | Oncostatin-M Receptor | ONECUT1 | ONECUT2 | ONECUT3 | OOEP | OOSP1 | OOSP2 | OPA1 | OPA1-AS1 | OPA3 | OPALIN | OPCML | OPHN1 | Opioid receptor | OPLAH | OPN1LW | OPN1MW | OPN1MW3 | OPN1SW | OPN3 | OPN4 | OPN5 | OPRD1 | OPRK1 | OPRL1 | OPRM1 | OPRPN | OPTC | OPTN | OR10A2 | OR10A3 | OR10A4 | OR10A5 | OR10A6 | OR10A7 | OR10AA1P | OR10AB1P | OR10AC1 | OR10AD1 | OR10AF1P | OR10AG1 | OR10AK1P | OR10C1 | OR10D1P | OR10D3 | OR10D4P | OR10G2 | OR10G3 | OR10G4 | OR10G7 | OR10G8 | OR10G9 | OR10H1 | OR10H2 | OR10H3 | OR10H4